Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed colorectal cancer: the prospective Streamline C trial
| dc.contributor.author | Taylor, SA | en_US |
| dc.contributor.author | Mallett, S | en_US |
| dc.contributor.author | Beare, S | en_US |
| dc.contributor.author | Bhatnagar, G | en_US |
| dc.contributor.author | Blunt, D | en_US |
| dc.contributor.author | Boavida, P | en_US |
| dc.contributor.author | Bridgewater, J | en_US |
| dc.contributor.author | Clarke, CS | en_US |
| dc.contributor.author | Duggan, M | en_US |
| dc.contributor.author | Ellis, S | en_US |
| dc.contributor.author | Glynne-Jones, R | en_US |
| dc.contributor.author | Goh, V | en_US |
| dc.contributor.author | Groves, AM | en_US |
| dc.contributor.author | Hameeduddin, A | en_US |
| dc.contributor.author | Janes, SM | en_US |
| dc.contributor.author | Johnston, EW | en_US |
| dc.contributor.author | Koh, D-M | en_US |
| dc.contributor.author | Miles, A | en_US |
| dc.contributor.author | Morris, S | en_US |
| dc.contributor.author | Morton, A | en_US |
| dc.contributor.author | Navani, N | en_US |
| dc.contributor.author | O'Donohue, J | en_US |
| dc.contributor.author | Oliver, A | en_US |
| dc.contributor.author | Padhani, AR | en_US |
| dc.contributor.author | Pardoe, H | en_US |
| dc.contributor.author | Patel, U | en_US |
| dc.contributor.author | Punwani, S | en_US |
| dc.contributor.author | Quinn, L | en_US |
| dc.contributor.author | Rafiee, H | en_US |
| dc.contributor.author | Reczko, K | en_US |
| dc.contributor.author | Rockall, AG | en_US |
| dc.contributor.author | Shahabuddin, K | en_US |
| dc.contributor.author | Sidhu, HS | en_US |
| dc.contributor.author | Teague, J | en_US |
| dc.contributor.author | Thaha, MA | en_US |
| dc.contributor.author | Train, M | en_US |
| dc.contributor.author | van Ree, K | en_US |
| dc.contributor.author | Wijeyekoon, S | en_US |
| dc.contributor.author | Halligan, S | en_US |
| dc.contributor.author | Investigators, S | en_US |
| dc.date.accessioned | 2019-05-13T13:35:28Z | |
| dc.date.available | 2019-02-10 | en_US |
| dc.date.issued | 2019-07 | en_US |
| dc.identifier.issn | 2468-1253 | en_US |
| dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/57416 | |
| dc.description.sponsorship | UK National Institute for Health Research | en_US |
| dc.format.extent | 529 - 537 | en_US |
| dc.language.iso | en | en_US |
| dc.relation.ispartof | LANCET GASTROENTEROLOGY & HEPATOLOGY | en_US |
| dc.rights | Attribution 4.0 International (CC BY 4.0) | |
| dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | |
| dc.title | Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed colorectal cancer: the prospective Streamline C trial | en_US |
| dc.type | Article | |
| dc.rights.holder | © 2019 The Author(s). | |
| dc.identifier.doi | 10.1016/S2468-1253(19)30056-1 | en_US |
| pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000470096400016&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
| pubs.issue | 7 | en_US |
| pubs.notes | Not known | en_US |
| pubs.publication-status | Published | en_US |
| pubs.volume | 4 | en_US |
| rioxxterms.funder | Default funder | en_US |
| rioxxterms.identifier.project | Default project | en_US |
Files in this item
| Files | Size | Format | View |
|---|---|---|---|
|
There are no files associated with this item. |
|||
This item appears in the following Collection(s)
Except where otherwise noted, this item's license is described as Attribution 4.0 International (CC BY 4.0)
